Title: Huggins Lectureship The Immune System and Cancer A Civil War
1Huggins LectureshipThe Immune System and
CancerA Civil War
- Saturdays
- January 12-March 1, 2008
- Judy Cannon Ph.D.
- Postdoctoral Fellow
- Department of Medicine, Section of Pulmonary and
Critical Care Medicine
2Quiz-from Week 1 lecture
- What are pathogens?
- Microorganisms that cause disease
- Viruses and fungi
- All bacteria
- What are two key players in the immune response?
- Red blood cells
- B and T cells
- Islet cells
- Cancer cells
- (A) Grow without normal control
- (B) Metastasize
- (C) Mutate DNA
- (D) All the above
- Immunotherapy is
- (A) Non specific cancer cell killing
- (B) Chemotherapy
- (C) Using the immune system to target and kill
cancer cells
3January 19th 2008Huggins Lecture
2Inflammation and the start of the adaptive
immune response
How does the immune system know when to go?
4Site of infection
Lymph Node
Tumor site
3. T cell recognition Self vs. non-self
2. Presentation of viral products Antigen
presentation
7. Target cell killing
Tumor cell
Virally infected cell
4. Lymphocyte expansion
6. Target recognition
Non-specific cell
Specific T cell
5. Lymphocyte trafficking Getting back to the
right location
Dendritic cell
Specific B cell
5Site of infection
Lymph Node
Tumor site
Tumor cell
Virally infected cell
Virally infected cell
Dendritic cell
6What is inflammation?
- Rubor redness-increased blood flow to site of
infection - Calor heat-increased blood flow and cellular
buildup. - Tumor swelling-increased cellular buildup at
site of infection - Dolor pain-chemical mediators that signal pain
to brain
7Mediators of inflammationInnate ImmunityFirst
responders
www.lib.mcg.edu/edu/esimmuno/ch1/physresp.htm
8Inflammation Maintaining balance
- Biological systems Need to be in balance.
- Too little leads to pathology.
- Too much leads to pathology.
9Inflammation
- How is it good?
- Leads to the start of the immune response
- How is it bad?
- Causes discomfort!
- Cancer
10What can cause too much inflammation?
- Chronic infections
- Hepatitis B and C-liver
- Helicobacter pylori-stomach ulcers
- Human Papilloma Virus-cervix
- Genetic diseases
- Inflammatory Bowel Disease
11Chronic inflammation and cancer
- Chronic infections
- Hepatitis B and C
- 20-30 times higher risk for liver cancer
- Ulcers caused by bacteria
- 3 times higher risk for stomach cancer
- Human Papilloma Virus
- Causes over 70 of all cases of cervical cancer
- Genetic diseases
- Inflammatory Bowel Disease
- 2-3 times higher risk for colon cancer
12How does inflammation cause cancer?
- Not clear
- Studies show that some of the mediators of
inflammation might cause DNA damage.
Treatments?
- Some evidence that anti-inflammatory drugs such
as aspirin might decrease cancer rates.
13When is inflammation good?
- Kicks off immune response.
- Signals from pathogens that tell the immune
system that we are infected with a pathogen.
14Coleys toxin
- Dr. William Coley
- Injected cancer patients with bacteria
- Saw dramatic regression or complete cure in a few
patients - Induce inflammation?
Courtesy Nature Publishing Group
15Mediators of inflammationInnate ImmunityRapid
Response Team Macrophages and Neutrophils
www.lib.mcg.edu/edu/esimmuno/ch1/physresp.htm
16Danger signals
www.biology.ualberta.ca/.../fly_lab/fly_lab.htm
17Drosophila Melanogaster
- One of the most intensively studied genetic
organisms - Classical genetic studies throughout 20th century
- Toll receptors identified in 1988.
- Important for fruit fly immunity to fungus
18Humans (and all mammals) have Toll-like
receptors, or TLRs
www.itb.cnr.it/
19TLRs signal danger to the immune system for
bacteria and viruses
Bacterial and viral components
20Site of infection
2. Presentation of pathogenic products Antigen
presentation
Virally infected cell
Dendritic cell
21Dendritic cells
- Reconaissance team
- Gather information to take to the specialists-
- army T cells
- air force B cells
- Dendritic cells start eating up nearby cells
- Dendritic cells chew up cellular material and
then display them to B and T cells - Dendritic cells move to lymph nodes
22Dendritic cells-bridging the local and the lymph
node response
23Figure 1-7
24Site of infection
Tumor site
Lymph Node
1. Inflammation
2. Antigen presentation
Tumor cell
Virally infected cell
Dendritic cell
25Infectious Agents vs. Cancer
- External bacteria or virus
26Site of infection
Tumor site
Lymph Node
1. Inflammation
2. Antigen presentation
Tumor cell
Virally infected cell
Dendritic cell
27An intelligence failure What happens if there
is no inflammation?
- No activation of local inflammatory response
- No activation of dendritic cells and adaptive
immune response - No antigen presentation-no T or B cell activation
28Imiquimod or Aldara
- FDA approved, on market now
- Used to treat superficial basal cell carcinoma
- Annual sales exceeded US 100 million
- TLR agonist binds and activates Toll-Like
receptor - Induces local inflammatory response
29Imiquimod-brings first responders
www.lib.mcg.edu/edu/esimmuno/ch1/physresp.htm
30Efficacy of Imiquimod
- In clinical trials, between 70-100 of patients
responded with complete clearance of basal cell
carcinoma. - Side effect edema, burning sensation
31Site of infection
Lymph Node
Tumor site
1. Inflammation
2. Antigen presentation
Tumor cell
Virally infected cell
Dendritic cell
32Key points Lecture 2
- Chronic inflammation can cause cancers.
- Inflammation is a necessary first step to the
immune response to bring first responders to
control the infection - Inflammation leads to activation of antigen
presentation and migration of dendritic cells to
lymph nodes - Activating inflammatory responses can lead to
clearance of certain types of tumors
33Next week Lecture 3Immune cell recognition
January 26th 2008
- How does the immune system see pathogens or
cancer cells? - Immune cell recognition, autoimmunity, and cancer
antigens.